China NMPA Product Recall - Blood glucose meter

On August 11, 2017, the National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Roche Diagnostics Products (Shanghai) Co., Ltd. The recall targeted several models of blood glucose meters, including devices registered under numbers such as 2008, 20122401580, 20142404948, 20142404375, and 2014240199. The core issue identified was the absence of essential biohazard warning labels on these medical devices. This oversight represents a deviation from required product safety labeling standards. In response, Roche Diagnostics Products (Shanghai) Co., Ltd. proactively undertook a Class III recall, which indicates that the use of or exposure to the affected product is unlikely to cause adverse health consequences. Comprehensive details regarding the specific models, specifications, and batch numbers of the recalled products were provided in an accompanying 'Medical Device Recall Event Report Form.' This action emphasizes the company's commitment, under NMPA's framework, to address regulatory compliance for medical device labeling and ensure user awareness regarding potential biohazards.